Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
Neuronetics gets another FDA clearance for transcranial magnetic stimulation system; shares jump 22%
08:57am, Tuesday, 19'th Jul 2022
Shares of Neuronetics Inc. STIM, -6.67% gained 22.5% in premarket trading on Tuesday after the company said it received clearance from the Food and Drug Administration to market its transcranial magne
Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
08:30am, Tuesday, 19'th Jul 2022
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve th
Read Why Neuronetics Shares Are Trading Higher Today
08:00am, Tuesday, 19'th Jul 2022
The FDA has cleared Neuronetics Inc's (NASDAQ: STIM) NeuroStar Advanced Therapy for Mental Health – to treat anxiety symptoms for adult patients with major depressive disorder (MDD), also known a
Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
12:31pm, Wednesday, 13'th Jul 2022 GlobeNewswire Inc.
Technology is awarded for its innovation to treat depression with NeuroStar Advanced Therapy for Mental Health Technology is awarded for its innovation to treat depression with NeuroStar Advanced Ther
Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health
08:46pm, Monday, 11'th Jul 2022 GlobeNewswire Inc.
Proposed Medicare Coverage through First Coast and Novitas MACs Will Reduce Number of Medication Trials for TMS Eligibility Proposed Medicare Coverage through First Coast and Novitas MACs Will Reduce
ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains?
11:43am, Monday, 27'th Jun 2022 Zacks Investment Research
ClearPoint Neuro, Inc. (CLPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
08:30pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve t
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
04:30pm, Wednesday, 25'th May 2022
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
12:31pm, Tuesday, 17'th May 2022 GlobeNewswire Inc.
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry
Neuronetics, Inc. (STIM) Q1 2022 Earnings Call Transcript
09:00pm, Thursday, 12'th May 2022 The Motley Fool
STIM earnings call for the period ending March 31, 2022.
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
12:45pm, Thursday, 12'th May 2022 Zacks Investment Research
Neuronetics (STIM) delivered earnings and revenue surprises of 0% and 7.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics' (STIM) CEO Keith Sullivan on Q1 2022 Results - Earnings Call Transcript
12:35pm, Thursday, 12'th May 2022
Neuronetics, Inc. (NASDAQ:STIM ) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Mark Klausner – Investor Relations Keith Sullivan – President and Chief Executive Off
Neuronetics Reports First Quarter 2022 Financial and Operating Results
11:30am, Thursday, 12'th May 2022 GlobeNewswire Inc.
MALVERN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever
Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
08:30pm, Wednesday, 11'th May 2022 GlobeNewswire Inc.
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever
Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
12:31pm, Wednesday, 11'th May 2022 GlobeNewswire Inc.
NeuroStar data from largest depression outcomes registry in the world to be highlighted NeuroStar data from largest depression outcomes registry in the world to be highlighted
